Skip to main content
Clinical Trials/NCT06476925
NCT06476925CompletedNot Applicable

Role of Left Stellate Ganglion Block in Offering Myocardial Protection in On-pump Mitral Valve Replacement? A Histopathological and Clinical Assessment

Minia University1 site in 1 country62 target enrollmentStarted: July 15, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
62
Locations
1
Primary Endpoint
Number of patients with microscopic myocardial injury

Study Overview

Brief Summary

Can pre-operative left stellate ganglion block offer myocardial protection in on-pump mitral valve replacement? A histopathological and clinical assessment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult population of both sex, between 25-50 years, will undergo elective on pump mitral valve replacement

Exclusion Criteria

  • -Combined valve replacement ( mitral and aortic or mitral and tricuspid valves replacement).
  • Emergency valve replacement ( stuck valve, infective endocarditis).
  • Pre-operative cardiomyopathy (Ejection fraction less than 45%).
  • Recent myocardial infarction ( within 6 months)
  • Redo mitral valve replacement.
  • Pre-operative pacing, or cardioverter, any form arrhythmia ( tachy or brady).
  • Previous history of carotid endarterectomy or presence of carotid stent.
  • On thrombolytic therapy.
  • Severe chronic obstructive airway disease,
  • Patient refusal

Arms & Interventions

Control group

Placebo Comparator

Sonar guided stellate ganglion injection of 8 ml of sterile saline 0.9% using high frequency probe as a placebo. Stellate ganglion is identified at the level of C6 just under the pulsation of the ipsilateral carotid artery

Intervention: sonar guided stellate ganglion injection (Procedure)

Stellate ganglion

Active Comparator

Sonar guided stellate ganglion injection of 8ml bupivacaine 0.25% using high frequency probe. . Stellate ganglion is identified at the level of C6 just under the pulsation of the ipsilateral carotid artery

Intervention: sonar guided stellate ganglion block (Procedure)

Outcomes

Primary Outcomes

Number of patients with microscopic myocardial injury

Time Frame: intra-operative

Biopsy from left papillary muscle to investigate microscopic evidence of cellular injury ( cytoplasmic oedema, hemorrhage and necrosis).

Secondary Outcomes

  • postoperative arrhythmia(first, second and third day after bypass)
  • Time of cardiopulmonary bypass(Intraoperative)
  • Myocardial function(pre-operative, one week)
  • weaning from mechanical ventilation(24 hours post-operative)
  • Length of ICU stay(one week)
  • Intra-operative arrhythmia(intraoperatively)
  • Troponin I(before operation, immediately after ICU admission and 3 days post-operative)
  • Need for pacing(intraoperative and one week after)

Investigators

Sponsor
Minia University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mina Maher

Ass professor anesthesia and pain

Minia University

Study Sites (1)

Loading locations...

Similar Trials